Skin vaccine using microneedle patch with inactivated RSV virus and an immune-stimulating compound as tested in mice is effective against RSV, a common respiratory disease that can be serious for young children. For children under 1 year old in the US, RSV is the most common cause of bronchiolitis.
No comments:
Post a Comment